Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
Titel:
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
Auteur:
Del Prato, Stefano Kahn, Steven E Pavo, Imre Weerakkody, Govinda J Yang, Zhengyu Doupis, John Aizenberg, Diego Wynne, Alan G Riesmeyer, Jeffrey S Heine, Robert J Wiese, Russell J